Section Arrow
NNNN.NASDAQ
- Anbio Biotechnology
Quotes are at least 15-min delayed:2026/05/19 15:40 EDT
Regular Hours
Last
 32
+3.85 (+13.68%)
Day High 
32.5 
Prev. Close
28.15 
1-M High
32.9383 
Volume 
13.41K 
Bid
31.7
Ask
35.49
Day Low
28.75 
Open
28.75 
1-M Low
22.89 
Market Cap 
1.24B 
Currency 美元 
P/E 228.03 
%Yield -- 
10-SMA 26.41 
20-SMA 27.23 
50-SMA 25.64 
52-W High 55.65 
52-W Low 7.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.15/--
Enterprise Value
1.24B
Balance Sheet
Book Value Per Share
0.69
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
8.65M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
WRBYWarby Parker24.88-3.77-13.16%2,513.5PE
XRAYDENTSPLY SIRONA9.725-0.095-0.97%-- 
MDLNMedline Inc37.62+1.6+4.44%32.95PE
AVTRAvantor7.72+0.12+1.58%-- 
NVSTEnvista Holdings Corp22.92-0.23-0.99%55.88PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improvepatient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.